REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 180 filers reported holding REGENXBIO INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,655,000 | -70.5% | 213,959 | -72.5% | 0.33% | -79.4% |
| Q2 2022 | $19,183,000 | -5.9% | 776,624 | +26.5% | 1.60% | +3.3% |
| Q1 2022 | $20,381,000 | -38.2% | 614,085 | -39.1% | 1.55% | -19.6% |
| Q4 2021 | $32,964,000 | +516.3% | 1,008,081 | +690.1% | 1.92% | +507.3% |
| Q3 2021 | $5,349,000 | -67.8% | 127,593 | -70.2% | 0.32% | -66.9% |
| Q2 2021 | $16,618,000 | +34.7% | 427,740 | +18.2% | 0.96% | +29.1% |
| Q1 2021 | $12,339,000 | +0.3% | 361,735 | +33.4% | 0.74% | +1.4% |
| Q4 2020 | $12,298,000 | +650.8% | 271,114 | +355.6% | 0.73% | +505.0% |
| Q3 2020 | $1,638,000 | – | 59,507 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |